Bioscience Biotechnology and Biochemistry · 2002 · 131 citations · 13 references
MedicineNeurosciencePharmacologyMolecular NeuroscienceNeurochemistryNeuropharmacologyGlutamatergic PharmacologyNeurochemical PharmacologyNeuroprotectionNeuroprotective PharmacologyNeurotransmissionSynaptic TransmissionCerebral Ischemia NeuroprotectionGlutamate Receptor AntagonismGlutamatergic NeuroprotectionGlutamatergic Transmission ModulationKainate Receptor PharmacologyKainate ReceptorsNeuroprotective MechanismsPharmacology Of Glutamate Receptors
In an investigation of the mechanisms of the neuroprotective effects of theanine (gamma-glutamylethylamide) in brain ischemia, inhibition by theanine of the binding of [3H](RS)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA), [3H]kainate, and [3H](E)-3-(2-phenyl-2-carboxyethenyl)-4,6-dichloro-1-H-indole-2-carboxylic acid (MDL 105,519) to glutamate receptors was studied in terms of its possible inhibiting effects on the three receptor subtypes (AMPA, kainate, and NMDA glycine), with rat cortical neurons. Theanine bound the three receptors, but its IC50 of theanine was 80- to 30,000-fold less than that of L-glutamic acid.
13
Calcium Dependence of Toxic Cell Death: A Final Common Pathway
Francis A.X. Schanne, Agnes B. Kane, Ellora E. Young et al. · Science · 1979 · 1.5K citations
Jan A. Gorter, Jeffrey J. Petrozzino, Eleonora Aronica et al. · Journal of Neuroscience · 1997 · 290 citations · Full text